https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Dental-MS.jpg

Dental Bone Graft Substitutes Market Size, Share & COVID19 Impact Analysis | China | 2021-2027 | MedSuite | Includes: Allografts, Xenografts, Synthetic Bone Grafts & Dental Barrier Membranes

  • Year: 2021
  • Scope: 2017-2027
  • Region: China
  • Pages: 147
  • Published Date: 01/12/2021
  • Type: MedSuite

In 2021, the China dental bone graft substitutes (DBGS) market size is projected to reach $146 million, with the Allograft and Xenograft markets showing the highest growth. In spite of COVID19, the Chinese market size is expected to increase with a compound annual growth rate of 28.8% to exceed an astounding $389 million in 2027.

China Dental Bone Graft Substitutes Market Size Growth, 2017-2027

The total Chinese dental bone graft substitutes market will be driven by the growing number of dental implants placed in China. China is considered the next big market for dental implants, a restoration closely linked to the dental bone graft substitute and dental barrier membrane markets. This, along with the bundling of implant products with biomaterials, will apply positive pressure on the Chinese market for dental bone grafts and other biomaterials.

A major limiter preventing market growth in the dental bone graft substitute market is the strict nature of China’s regulatory approval process. Medical equipment and products sold in China undergo stringent regulation through the China Food & Drug Administration (CFDA). Foreign manufacturers often face a more difficult registration and licensing process due to these requirements, such as clinical trials on their products that have taken place within China.

DATA TYPES INCLUDED IN THIS STUDY

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Market Forecasts Until 2027 & Historical Data to 2017
  • Competitive Analysis with Market Shares for Each Market Segment
  • Market Drivers & Limiters for Each Dental Bone Graft Substitute Market
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Dental Bone Graft Substitutes Market in China
  • Disease Overviews & Demographic Information
  • Company Profiles, Product Portfolios & SWOT for Top Competitors

China DBGS Market Segmentation

While this report suite contains all China dental bone graft substitutes market data, each of the market segments is also available as a stand-alone MedCore report. This allows you to get access to only the dental bone graft substitutes market research that you need.

  • Dental Bone Graft Substitute Market | China | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
    • Device Type: Mineralized Allografts, Xenografts, and Synthetic Bone Grafts.
  • Dental Barrier Membrane Market | China | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
    • Device Type: Resorbable and Non-Resorbable Dental Barrier Membranes.

China DBGS Market Share Insights

The total Chinese dental bone graft substitutes market is led by Geistlich. In second and third leading positions are Shanxi OsteoRad and Genoss. Geistlich, a globally recognized leader in regenerative materials, dominated the growing xenograft market in China. Geistlich’s success in the market has generated significant growth for xenograft materials, as the company is a globally recognized and trusted name. Through setting up an affiliate in China, the company has been able to combat local cultural barriers and build brand awareness in the market, further expanding its market share.

Top Chinese Dental Bone Graft Substitutes Companies Analyzed

  • Allgens
  • Beijing YHJ Science and Trade Co.
  • Bicon
  • Curasan
  • DENTIS
  • DSM
  • Geistlich
  • Genoss
  • Halma
  • Osteogenics
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad
  • Sunmax Biotechnology
  • Sunstar
  • Tianjin Sannie
  • Tissue Banks
  • Zhengzhou Smile Industrial
  • Zimmer Biomet

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
 

FREE Sample Report

China DENTAL BONE GRAFT SUBSTITUTE & OTHER BIOMATERIALS MARKET

TABLE OF CONTENTS I
LIST OF FIGURES VI
LIST OF CHARTS IX
EXECUTIVE SUMMARY 1
CHINA DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
VERSION HISTORY 7
RESEARCH METHODOLOGY 8
Step 1: Project Initiation & Team Selection 8
Step 2: Prepare Data Systems and Perform Secondary Research 11
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21

IMPACT OF COVID-19 ON THE CHINA DENTAL BONE GRAFT SUBSTITUTES AND OTHER BIOMATERIALS MARKET

2.1 INTRODUCTION 22
2.2 ANALYSIS BY MARKET SEGMENT 24
2.2.1 Best Case Scenario 24
2.2.2 Base Case Scenario 25
2.2.3 Worst Case Scenario 26

DISEASE OVERVIEW

3.1 BASIC ANATOMY 28
3.1.1 Dental Anatomy: Oral Cavity and Intraoral Landmarks 28
3.2 DISEASE PATHOLOGY AND DISORDERS 29
3.2.1 General Diagnostics 29
3.2.2 Indication for Dental Implant 29
3.2.3 Periodontal Disease 30
3.2.4 Dental Implant Procedures 31
3.2.5 Guided Bone Regeneration 32
3.3 PATIENT DEMOGRAPHICS 33
3.3.1 General Dental Statistics 33
3.3.2 Tooth Loss Statistics 34

PRODUCT ASSESSMENT

4.1 INTRODUCTION 36
4.2 PRODUCT PORTFOLIOS 36
4.2.1 Dental Bone Graft Substitutes 36
4.2.1.1 Allografts 37
4.2.1.1.1 Mineralized Allografts 37
4.2.1.1.2 Demineralized Bone Matrix 37
4.2.1.2 Autografts 38
4.2.1.3 Synthetics 39
4.2.1.4 Xenografts 40
4.2.2 Dental Growth Factors 43
4.2.3 Dental Barrier Membrane 44
4.3 REGULATORY ISSUES AND RECALLS 46
4.3.1 Geistlich 46
4.4 CLINICAL TRIALS 47
4.4.1 Dental Grafts 47

CHINA DENTAL BONE GRAFT SUBSTITUTE & OTHER BIOMATERIALS MARKET OVERVIEW

5.1 INTRODUCTION 50
5.1.1 Applications of Dental Bone Graft Substitutes 50
5.1.1.1 Dental Implant Procedures 51
5.1.1.2 Periodontal Procedures 51
5.1.2 Types of Dental Bone Graft Substitutes 51
5.1.2.1 Autografts 51
5.1.2.2 Allografts 52
5.1.2.3 Demineralized Bone Matrix Allografts 53
5.1.2.4 Xenografts 53
5.1.2.5 Synthetics 53
5.1.3 Dental Growth Factor Products 54
5.1.4 Dental Membranes 54
5.1.5 Market Penetration and End Users 55
5.2 CURRENCY EXCHANGE RATE 56
5.3 MARKET OVERVIEW 57
5.4 TREND ANALYSIS BY SEGMENT 63
5.5 DRIVERS AND LIMITERS 65
5.5.1 Market Drivers 65
5.5.2 Market Limiters 67
5.6 COMPETITIVE MARKET SHARE ANALYSIS 69
5.7 MERGERS AND ACQUISITIONS 74
5.8 COMPANY PROFILES 75
5.8.1 ACE Surgical 75
5.8.2 BioHorizons 76
5.8.3 Dentsply Sirona 77
5.8.4 Geistlich 78
5.8.5 LifeNet Health 79
5.8.6 Medtronic 80
5.8.7 Osteogenics Biomedical 81
5.8.8 Zimmer Biomet 82
5.9 SWOT ANALYSIS 83
5.9.1 ACE Surgical 84
5.9.2 BioHorizons 85
5.9.4 Dentsply Sirona 86
5.9.5 Geistlich 87
5.9.6 LifeNet Health 88
5.9.7 Medtronic 89
5.9.8 Osteogenics Biomedical 90
5.9.9 Zimmer Biomet 91

DENTAL BONE GRAFT SUBSTITUTE MARKET

6.1 INTRODUCTION 92
6.1.1 Autografts 92
6.1.2 Allografts 93
6.1.2.1 Mineralized Allografts 93
6.1.2.2 Demineralized Bone Matrix 93
6.1.3 Xenografts 94
6.1.4 Synthetics 95
6.2 MARKET OVERVIEW 96
6.3 MARKET ANALYSIS AND FORECAST 101
6.3.1 Total Dental Bone Graft Substitute Market 101
6.3.2 Allograft Market 104
6.3.3 Xenograft Market 107
6.3.4 Synthetic Market 110
6.4 DRIVERS AND LIMITERS 113
6.4.1 Market Drivers 113
6.4.2 Market Limiters 114
6.5 COMPETITIVE MARKET SHARE ANALYSIS 117

DENTAL BARRIER MEMBRANE MARKET

7.1 INTRODUCTION 122
7.2 MARKET OVERVIEW 125
7.3 MARKET ANALYSIS AND FORECAST 131
7.3.1 Dental Barrier Membrane Market 131
7.3.2 Resorbable Dental Barrier Membrane Market 134
7.3.3 Non-Resorbable Dental Barrier Membrane Market 137
7.4 DRIVERS AND LIMITERS 140
7.4.1 Market Drivers 140
7.4.2 Market Limiters 141
7.5 COMPETITIVE MARKET SHARE ANALYSIS 143

ABBREVIATIONS

Top Chinese Dental Bone Graft Substitutes Companies Analyzed

  • Allgens
  • Beijing YHJ Science and Trade Co.
  • Bicon
  • Curasan
  • DENTIS
  • DSM
  • Geistlich
  • Genoss
  • Halma
  • Osteogenics
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad
  • Sunmax Biotechnology
  • Sunstar
  • Tianjin Sannie
  • Tissue Banks
  • Zhengzhou Smile Industrial
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology